Non-muscle invasive bladder cancer: New standards in endoscopic management and adjuvant instillations
Poster Session 49
-
Location:Room Madrid, North Hall (Level 1)
-
Chairs:
-
Aims and objectives of this session Non-muscle invasive bladder cancer (NMIBC) comprises a heterogeneous group in which tumour number, size, grade and pathological stage (pT) are important prognostic factors related to the risk of recurrence, progression and survival. Transurethral resection of bladder tumour (TURBT) is the reference treatment of NMIBC. The accepted standard for “correct” TURBT is complete macroscopic tumour clearance with specimens of the tumour base and resection border sent separately. A key feature of the pathology report is the presence and/or invasion of lamina propria or muscularis propria, the latter being dependent upon the presence of detrusor muscle (DM) in the TURBT specimens. It is now well established that a “correct” TURBT positively influences recurrence and progression. This session aims to provide an overview of new techniques available to improve the quality of TURBT and the deliverance of adjuvant bladder instillations.
- Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion.
Institutes: 1Istituto Clinico Humanitas, Dept. of Urology, Rozzano, Italy, 2Istituto Clinico Humanitas, Dept. of Pathology, Rozzano, Italy
Institutes: 1Villa Betania Hospital, Rome, Italy, 2Villa Claudia Clinic, Dept. of Urology, Rome, Italy, 3University Campus Bio-Medico, Dept. of Urology, Rome, Italy
Institutes: 1Academic Medical Center, Dept. of Urology, Amsterdam, The Netherlands, 2Centre Hospitalier De L’Universite De Montreal, Dept. of Urology, Montreal, Canada, 3Chinese University of Hong Kong, HKSAR, Dept. of Surgery, Hong Kong, China, 4Kyoto University, Dept. of Urology, Kyoto, Japan, 5Saint John Emergency Clinical Hospital, Dept. of Urology, Bucharest, Romania, 6Yonsei University College of Medicine, Dept. of Urology, Seoul, South Korea, 7Sheikh Khalifa General Hospital, Dept. of Urology, Umm Al Quwain, United Arab Emirates, 8Duke University Medical Center, Dept. of Urology, Durham, United States of America, 9Harasanshin Hospital, Dept. of Urology, Fukuoka, Japan
Institutes: 1Eberhard-Karls University, Dept. of Urology, Tübingen, Germany, 2Ludwig-Maximillians University, Dept. of Urology, Munich, Germany, 3Friedrich-Alexander University, Dept. of Pathology, Erlangen, Germany, 4Caritas St. Joseph´s Hospital, University of Regensburg, Dept. of Urology, Regensburg, Germany, 5Charite, University Medicine Berlin, Dept. of Urology, Berlin, Germany, 6Diakonie-Klinikum, Dept. of Urology, Stuttgart, Germany, 7Friedrich-Alexander University, Dept. of Urology, Erlangen, Germany
Institutes: 1Memorial Sloan Kettering Cancer Center, Dept. of Urology, New York, United States of America, 2Memorial Sloan Kettering Cancer Center, Dept. of Biostatistics, New York, United States of America
Institutes: 1Institut Universitaire Du Cancer, Dept. of Pathology, Toulouse, France, 2Institut Universitaire Du Cancer, Dept. of Urology, Toulouse, France
Institutes: 1University College Hospitals London, Dept. of Surgery and Interventional Sciences, London, United Kingdom, 2Universitat Autònoma De Barcelona – Fundació Puigvert, Dept. of Urology, Barcelona, Spain
Institutes: University of Turin, Città Della Salute E Della Scienza Di Torino, Dept. of Surgical Sciences, Division of Urology, Turin, Italy
Institutes: 1Fundació Puigvert, Dept. of Urology, Barcelona, Spain, 2A.O. Città Della Salute E Della Scienza, University of Turin, Dept. of Urology, Turin, Italy, 3University Hospitals Leuven, Dept. of Urology, Leuven, Belgium, 4Paolo Giaccone General Hospital, Dept. of Urology, Palermo, Italy, 5John Radcliffe Hospital, University of Oxford, Dept of Surgical Science, Oxford, United Kingdom, 6Policlinico Tor Vergata-University of Rome, Dept of Urology, Rome, Italy, 7Netherlands Cancer Institute – Antoni Van Leeuwenhoek Hospital, Dept of Urology, Amsterdam, The Netherlands, 8Radboud University Nijmegen Medical Centre, Dept of Urology, Nijmegen, The Netherlands, 9Universit A Vita-Salute. Ospedale S. Raffaele, Dept of Urology, Milan, Italy, 10Motol Hospital, University of Praha, Dept of Urology, Prague, Czech Republic, 11Cademic Hospital, Uppsala University, Dept of Urology, Uppsala, Sweden, 12Centre Hospitalier Universitaire La Mil Etrie, University of Poitiers, Dept of Urology, Poitiers, France, 13Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Centre, Dept. of Genetics, Madrid, Spain, 14Rabin Medical Centre, Dept. of Urology, Tel Aviv, Israel, 15Santa Chiara Hospital, Dept. of Urology, Trento, Italy, 16Weill Medical College of Cornell University, Dept. of Urology, New York, United States of America, 17Chirurgische Universitats Klini, Dept. of Urology, Freiburg, Germany, 18Ismanoglio Hospital, University of Athens, Dept. of Urology, Athens, Greece, 19University of Florences, Dept. of Experimental and Clinical Medicine, Athens, Greece, 20Memorial Sloan Kettering Cancer Center, New York, Dept. of Urology, New York, United States of America, 21Medical University of Vienna, Dept. of Urology, Vienna, Austria, 22Mayo Clinic, Dept. of Urology, Rochester, United States of America, 23ORTC Headquarters, Formerly Department of Biostatistics,, Brussels, Belgium
Institutes: 1University College London, Division of Surgery and Interventional Science, London, United Kingdom, 2University of Birmingham, Cancer Research UK Clinical Trials Unit, Birmingham, United Kingdom, 3University College London Hospitals, Dept. of Urology, London, United Kingdom, 4James Cook University Hospital, Dept. of Urology, Middlesbrough, United Kingdom, 5St George’s Hospital, Dept. of Urology, London, United Kingdom, 6Basingstoke and North Hampshire Hospital, Dept. of Urology, London, United Kingdom, 7Darent Valley Hospital, Dept. of Urology, Dartford, United Kingdom, 8Queen Elizabeth Hospital, Dept. of Urology, Birmingham, United Kingdom, 9Royal Devon and Exeter Hospital, Dept. of Urology, Exeter, United Kingdom, 10Withington Hospital, Dept. of Urology, Manchester, United Kingdom, 11Leicester General Hospital, Dept. of Urology, Leicester, United Kingdom, 12Freeman Hospital, Dept. of Urology, Newcastle, United Kingdom, 13Queen Alexandra Hospital, Dept. of Urology, Portsmouth, United Kingdom, 14University Hospital of Wales, Dept. of Urology, Cardiff, United Kingdom
Institutes: Celal Bayar University, Faculty of Medicine, Dept. of Urology, Manisa, Turkey